This inventor holds 3 USPTO granted patents. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kogyo Kabushiki Kaisha, Kyowa Hakko Rogyo Kabushiki Kaisha. Active years: 1987-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Machida, JP (1987)
- Sakai, JP (1991)
- Osaka, JP (1992)
Company Filing History:
1 out of 730 
1 out of 45 
1 out of 1 Years Active: 1987-1992
Title: Tohru Yasuzawa: Pioneering Innovations in Cerebral and Antitumor Compounds
Introduction
Tohru Yasuzawa is a distinguished inventor based in Sakai, Japan, recognized for his contributions to the field of biotechnology. With a track record of three patents, his work focuses on the development of novel compounds aimed at improving cerebral function and addressing critical health challenges, particularly in the areas of memory enhancement and cancer treatment.
Latest Patents
Tohru Yasuzawa's latest patents include a groundbreaking compound known as KS-505, which exhibits amnesia-inhibiting activity. This innovative compound can be prepared through the fermentation of a suitable strain of Streptomyces, specifically the Streptomyces argenteolus A-2 (FERM BP-2065). In addition to KS-505, he has developed a novel derivative of DC-88A, which is characterized by its impressive antitumor properties, represented by a specific general formula. This derivative demonstrates significant potential as an effective antitumor agent, showcasing Yasuzawa's commitment to addressing vital medical issues through innovative solutions.
Career Highlights
Throughout his career, Tohru Yasuzawa has made significant strides while working with prominent organizations such as Kyowa Hakko Rōgō Kabushiki Kaisha and Kyowa Hakko Kogyo Co., Ltd. His dedication to research and development in these esteemed companies has enabled him to contribute effectively to scientific advancements, particularly in pharmaceuticals and biotechnology.
Collaborations
Yasuzawa's work has been enriched through collaborations with accomplished colleagues, including Hiroshi Kase and Isao Kawamoto. These partnerships have fostered an environment of shared knowledge and innovation, facilitating the successful development of critical compounds that have the potential to transform healthcare practices.
Conclusion
Tohru Yasuzawa's inventive spirit and dedication to research continue to leave a lasting impact on the fields of cerebral health and cancer treatment. His innovative compounds, such as KS-505 and the DC-88A derivative, highlight his role as a key player in advancing medical science. As he continues to pursue new avenues of research, the potential for further groundbreaking contributions remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile